Source: Antimicrobial Agents and Chemotherapy. Unidade: FCF
Subjects: TRYPANOSOMA CRUZI, ENZIMAS, DOENÇA DE CHAGAS (TRATAMENTO), FARMACOCINÉTICA
ABNT
SERAFIM, Eliana Ometto Pavan et al. Pharmacokinetics of hydroxymethylnitrofurazone, a promising new prodrug for Chagas' disease treatment. Antimicrobial Agents and Chemotherapy, v. 57, n. 12, p. 6106-6109, 2013Tradução . . Disponível em: https://doi.org/10.1128/AAC.02522-12. Acesso em: 21 jul. 2024.APA
Serafim, E. O. P., Silva, A. T. de A., Moreno, A. de H., Vizioli, E. de O., Ferreira, E. I., Peccinini, R. G., et al. (2013). Pharmacokinetics of hydroxymethylnitrofurazone, a promising new prodrug for Chagas' disease treatment. Antimicrobial Agents and Chemotherapy, 57( 12), 6106-6109. doi:10.1128/AAC.02522-12NLM
Serafim EOP, Silva AT de A, Moreno A de H, Vizioli E de O, Ferreira EI, Peccinini RG, Ribeiro ML, Chung MC. Pharmacokinetics of hydroxymethylnitrofurazone, a promising new prodrug for Chagas' disease treatment [Internet]. Antimicrobial Agents and Chemotherapy. 2013 ; 57( 12): 6106-6109.[citado 2024 jul. 21 ] Available from: https://doi.org/10.1128/AAC.02522-12Vancouver
Serafim EOP, Silva AT de A, Moreno A de H, Vizioli E de O, Ferreira EI, Peccinini RG, Ribeiro ML, Chung MC. Pharmacokinetics of hydroxymethylnitrofurazone, a promising new prodrug for Chagas' disease treatment [Internet]. Antimicrobial Agents and Chemotherapy. 2013 ; 57( 12): 6106-6109.[citado 2024 jul. 21 ] Available from: https://doi.org/10.1128/AAC.02522-12